PATENT CLAIM ANALYSIS

Application Number: 15742408
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["435", "006110"]

Abstract:
The present invention relates to a method for determining sensitivity to a simultaneous inhibitor against poly ADP ribose polymerase (PARP) and Tankyrase. According to the present invention, a colorectal treatment effect can be maximized by sorting patients having sensitivity to the simultaneous inhibitor against PARP and Tankyrase.

Claim (Index 2):
The method according to  claim 1 , wherein the step (c) is performed by DNA sequencing, Polymerase Chain Reaction (PCR), Restriction Fragment Length Polymorphism (RFLP), Random Amplified Polymorphic Detection (RAPD), Amplified Fragment Length Polymorphism Detection (AFLPD), ASO (Allele Specific Oligonucleotide) probe or DNA microarray.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 86.0
- Lexical Diversity: 1.44444
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['09813824', '09174493', '11679803', '10555507', '13952561']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6233890999763271
- 35 USC 102 Novelty (BERT): 0.5013610725305304
- Combined Prediction Score: 0.6111862972317474
- Mean Citation Score: 239.035248
- Max Citation Score: 244.26163
- Similarity Product: 164.88628498173833

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test